A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo

被引:154
作者
Verdoes, Martijn
Florea, Bogdan I.
Menendez-Benito, Victoria
Maynard, Christa J.
Witte, Martin D.
van der Linden, Wouter A.
van den Nieuwendijk, Adrianus M. C. H.
Hofmann, Tanja
Berkers, Celia R.
van Leeuwen, Fijs W. B.
Groothuis, Tom A.
Leeuwenburgh, Michiel A.
Ovaa, Huib
Neefjes, Jacques J.
Filippov, Dmitri V.
van der Marel, Gijs A.
Dantuma, Nico P.
Overkleeft, Herman S. [1 ]
机构
[1] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands
[2] Karolinska Inst, Dept Cell & Mol Biol, Med Nobel Inst, SE-17177 Stockholm, Sweden
[3] Netherlands Canc Inst, Div Cellular Biochem, NL-1066 CX Amsterdam, Netherlands
[4] Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands
来源
CHEMISTRY & BIOLOGY | 2006年 / 13卷 / 11期
关键词
D O I
10.1016/j.chembiol.2006.09.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The proteasome is an essential evolutionary conserved protease involved in many regulatory systems. Here, we describe the synthesis and characterization of the activity-based, fluorescent, and cell-permeable inhibitor Bodipy TMR-Ahx(3)L(3)VS (MV151), which specifically targets all active subunits of the proteasome and immunoproteasome in living cells, allowing for rapid and sensitive in-gel detection. The inhibition profile of a panel of commonly used proteasome inhibitors could be readily determined by MV151 labeling. Administration of MV151 to mice allowed for in vivo labeling of proteasomes, which correlated with inhibition of proteasomal degradation in the affected tissues. This probe can be used for many applications ranging from clinical profiling of proteasome activity, to biochemical analysis of subunit specificity of inhibitors, and to cell biological analysis of the proteasome function and dynamics in living cells.
引用
收藏
页码:1217 / 1226
页数:10
相关论文
共 18 条
[1]   The proteasome:: Paradigm of a self-compartmentalizing protease [J].
Baumeister, W ;
Walz, J ;
Zühl, F ;
Seemuller, E .
CELL, 1998, 92 (03) :367-380
[2]   Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomib [J].
Berkers, CR ;
Verdoes, M ;
Lichtman, E ;
Fiebiger, E ;
Kessler, BM ;
Anderson, KC ;
Ploegh, HL ;
Ovaa, H ;
Galardy, PJ .
NATURE METHODS, 2005, 2 (05) :357-362
[3]   Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors [J].
Bogyo, M ;
McMaster, JS ;
Gaczynska, M ;
Tortorella, D ;
Goldberg, AL ;
Ploegh, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (13) :6629-6634
[4]   Syntheses and properties of benzodipyrrinones [J].
Boiadjiev, SE ;
Lightner, DA .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 2003, 40 (01) :181-185
[5]   Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells [J].
Dantuma, NP ;
Lindsten, K ;
Glas, R ;
Jellne, M ;
Masucci, MG .
NATURE BIOTECHNOLOGY, 2000, 18 (05) :538-543
[6]  
Haugland R.P., 1988, US pat, Patent No. [4,774,339, 4774339]
[7]  
Hideshima T, 2001, CANCER RES, V61, P3071
[8]   COLOR TEST FOR DETECTION OF FREE TERMINAL AMINO GROUPS IN SOLID-PHASE SYNTHESIS OF PEPTIDES [J].
KAISER, E ;
COLESCOT.RL ;
BOSSINGE.CD ;
COOK, PI .
ANALYTICAL BIOCHEMISTRY, 1970, 34 (02) :595-&
[9]  
KANG HC, 1993, Patent No. 5274113
[10]  
KANG HC, 1995, Patent No. 5451663